Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Cell Death & Disease
|
July 6, 2012
Granzyme B triggers a prolonged pressure to die in Bcl-2 overexpressing cells, defining a window of opportunity for effective treatment with ABT-737
V R Sutton, K Sedelies, G Dewson, et al.
European Journal of Medicinal Chemistry
|
March 3, 2020
Substituted 1-methyl-4-phenylpyrrolidin-2-ones - Fragment-based design of N-methylpyrrolidone-derived bromodomain inhibitors
J P Hilton-Proctor, O Ilyichova, Z Zheng, et al.
Leukemia
|
March 11, 2017
A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML
L M Kats, S J Vervoort, R Cole, et al.
Cell Death & Disease
|
September 14, 2013
Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma
G M Matthews, M Lefebure, M A Doyle, et al.
Leukemia
|
January 13, 2015
CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
G P Gregory, S J Hogg, L M Kats, et al.
Molecular and Cellular Biology
|
December 1, 1996
A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1
R W Johnstone, R H See, S F Sells, et al.
Cell Death and Differentiation
|
January 19, 2008
Blocking granule-mediated death by primary human NK cells requires both protection of mitochondria and inhibition of caspase activity
K A Sedelies, A Ciccone, C J P Clarke, et al.
Cell Death & Disease
|
October 13, 2012
Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor
L M Lindqvist, I Vikström, J M Chambers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 2, 2007
Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma
R K Lindemann, A Newbold, K F Whitecross, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Cell Death & Disease
|
July 6, 2012
Granzyme B triggers a prolonged pressure to die in Bcl-2 overexpressing cells, defining a window of opportunity for effective treatment with ABT-737
V R Sutton, K Sedelies, G Dewson, et al.
European Journal of Medicinal Chemistry
|
March 3, 2020
Substituted 1-methyl-4-phenylpyrrolidin-2-ones - Fragment-based design of N-methylpyrrolidone-derived bromodomain inhibitors
J P Hilton-Proctor, O Ilyichova, Z Zheng, et al.
Leukemia
|
March 11, 2017
A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML
L M Kats, S J Vervoort, R Cole, et al.
Cell Death & Disease
|
September 14, 2013
Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma
G M Matthews, M Lefebure, M A Doyle, et al.
Leukemia
|
January 13, 2015
CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
G P Gregory, S J Hogg, L M Kats, et al.
Molecular and Cellular Biology
|
December 1, 1996
A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1
R W Johnstone, R H See, S F Sells, et al.
Cell Death and Differentiation
|
January 19, 2008
Blocking granule-mediated death by primary human NK cells requires both protection of mitochondria and inhibition of caspase activity
K A Sedelies, A Ciccone, C J P Clarke, et al.
Cell Death & Disease
|
October 13, 2012
Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor
L M Lindqvist, I Vikström, J M Chambers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 2, 2007
Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma
R K Lindemann, A Newbold, K F Whitecross, et al.
Page
of 10